Related Experiment Videos
Fluoroquinolones in respiratory infections.
1Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501.
Seminars in Respiratory Infections
|September 1, 1991
Summary
Fluoroquinolones are effective against many respiratory pathogens, including specific gram-negative bacteria. However, their limited activity against Streptococcus pneumoniae and anaerobes restricts their use in certain pneumonia cases.
Area of Science:
- Infectious Diseases
- Pharmacology
- Respiratory Medicine
Background:
- Fluoroquinolones demonstrate potent activity against key respiratory pathogens.
- Gram-negative bacteria, such as beta-lactamase-producing Hemophilus influenzae and Moraxella catarrhalis, are particularly susceptible.
Purpose of the Study:
- To evaluate the efficacy of fluoroquinolones in treating various respiratory infections.
- To identify the spectrum of activity and limitations of fluoroquinolone use in respiratory care.
Main Methods:
- Review of existing studies on fluoroquinolone treatment for respiratory infections.
- Analysis of antimicrobial activity against common respiratory pathogens.
Main Results:
- Ciprofloxacin has shown effectiveness in treating acute exacerbations of chronic bronchitis.
- Studies support its use in community-acquired and nosocomial pneumonia, and cystic fibrosis exacerbations.
- Fluoroquinolones exhibit reduced activity against Streptococcus pneumoniae and anaerobic bacteria.
Conclusions:
- Fluoroquinolones are valuable for specific respiratory infections, especially those caused by susceptible gram-negative bacteria.
- Their limitations against Streptococcus pneumoniae and anaerobes necessitate caution in empiric therapy for community-acquired pneumonia.
- Clinical decisions should consider pathogen prevalence and susceptibility patterns.